Press Releases on September 5, 2017 - EIN Presswire - Press Release Distribution Service

Published on September 5, 2017 - 12:00 GMT

Sunrun to Participate at Investor Conferences in September 2017

SAN FRANCISCO, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Sunrun (Nasdaq:RUN), the largest dedicated residential solar, storage and energy services company in the United States, today announced members of Sunrun’s management team will participate in the following …

Distribution channels: Conferences & Trade Fairs, Energy Industry

Published on September 5, 2017 - 12:00 GMT

John G. Stallings, Jr. Named President of Union Bank & Trust

RICHMOND, Va., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Union Bank & Trust has named John Stallings, President effective September 29. A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/60eb27c7-ea41- …

Distribution channels: Banking, Finance & Investment Industry

Published on September 5, 2017 - 12:00 GMT

Aclaris Therapeutics Announces Issuance of Two U.S. Patents Covering JAK Inhibitors for Treating Hair Loss Disorders

MALVERN, Pa., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company focused on identifying, developing and commercializing innovative and differentiated therapies to address significant …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 5, 2017 - 12:00 GMT

Remark Holdings, Inc. to Present at the 6th Annual Liolios Gateway Conference on September 7, 2017

LAS VEGAS, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Remark Holdings (NASDAQ:MARK) has been invited to present at the 2017 Gateway Conference, which is being held on September 6-7, 2017 at the Four Seasons Hotel San Francisco. Remark Holdings, Inc. management is …

Distribution channels: Conferences & Trade Fairs, IT Industry

Published on September 5, 2017 - 12:00 GMT

Alder BioPharmaceuticals® to Present at the Morgan Stanley 15th Annual Global Healthcare Conference

BOTHELL, Wash., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR), a clinical-stage biopharmaceutical company developing monoclonal antibody therapeutics today announced that it will webcast its presentation at the upcoming …

Distribution channels: Technology

Published on September 5, 2017 - 12:00 GMT

Corium to Present at Upcoming Healthcare Conferences

MENLO PARK, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq:CORI), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty transdermal products, today announced …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry

Published on September 5, 2017 - 12:00 GMT

Bio-Path Holdings to Present at the Rodman & Renshaw Annual Healthcare Conference

HOUSTON, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize™ liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, …

Distribution channels: Technology

Published on September 5, 2017 - 12:00 GMT

Retrophin Announces Cooperative Research and Development Agreement with NCATS and NGLY1.org to Identify Potential Small Molecule ...

SAN DIEGO, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ:RTRX) today announced that it has entered into a three-way Cooperative Research and Development Agreement (CRADA) with the National Institutes of Health’s National Center for Advancing …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 5, 2017 - 12:00 GMT

Global Blood Therapeutics Receives Rare Pediatric Disease Designation from FDA for GBT440 for Treatment of Sickle Cell Disease (...

SOUTH SAN FRANCISCO, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease designation to GBT440 for the treatment …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 5, 2017 - 12:00 GMT

UNIVISION AND ROSETTA STONE LAUNCH ENGLISH-LANGUAGE LEARNING PROGRAM FOR HISPANIC AUDIENCE

New York, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Univision Communications Inc. (UCI), the leading media company serving Hispanic America, today announced it has entered into a new partnership with language education powerhouse Rosetta Stone Inc. (NYSE: RST), a …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on September 5, 2017 - 12:00 GMT

Editas Medicine to Participate in Morgan Stanley 15th Annual Global Healthcare Conference

CAMBRIDGE, Mass., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that management will participate in a fireside chat at the Morgan Stanley 15th Annual Global Healthcare Conference …

Distribution channels: Technology

Published on September 5, 2017 - 12:00 GMT

Select Sands Receives Offer to Purchase Its Ownership Position in Comstock Metals

VANCOUVER, British Columbia, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Select Sands Corp. (“Select Sands” or the “Company”) (TSX-V:SNS) (OTC:SLSDF) announces that it has received an offer from SJ Strategic Investments, LLC, Gracetree Investments, LLC, Gregory …

Distribution channels: Mining Industry

Published on September 5, 2017 - 12:00 GMT

Air Canada Flights Fuelled by Freshii

TORONTO, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Freshii Inc. (TSX:FRII) is one of the world’s fastest growing health and wellness brands, on a mission to make healthy food convenient and affordable for all. In continuing to deliver on that mission, Freshii is …

Distribution channels: Food & Beverage Industry

Published on September 5, 2017 - 12:00 GMT

Caladrius Biosciences Announces Enrollment of the 70th Subject in the Phase 2 T-Rex Clinical Trial of CLBS03 for Type 1 Diabetes

BASKING RIDGE, N.J., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (NASDAQ:CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms targeting autoimmune and select cardiology …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 5, 2017 - 12:00 GMT

Biotricity FDA Submission Update

REDWOOD CITY, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Biotricity, Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, is pleased to announce that …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on September 5, 2017 - 12:00 GMT

Fortress Biotech to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

NEW YORK, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (NASDAQ:FBIO) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology products, today announced that Lindsay …

Distribution channels: Conferences & Trade Fairs, Technology

Published on September 5, 2017 - 12:00 GMT

Cynata to Present at the 19th Annual Rodman & Renshaw Global Investment Conference in New York

MELBOURNE, Australia, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Australian stem cell and regenerative medicine company, Cynata Therapeutics Limited (ASX:CYP), announced today it will be featured as a presenting company at the 19th Annual Rodman & Renshaw …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry

Published on September 5, 2017 - 12:00 GMT

Checkpoint Therapeutics to Present at the 19th Annual Rodman & Renshaw Global Investment Conference

NEW YORK, Sept. 05, 2017 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (NASDAQ:CKPT), a Fortress Biotech (NASDAQ:FBIO) company, today announced that James F. Oliviero, President and Chief Executive Officer of Checkpoint, will present a …

Distribution channels: Conferences & Trade Fairs, Technology

Published on September 5, 2017 - 12:00 GMT

Atara Biotherapeutics Receives FDA Orphan Drug Designation for ATA230

SOUTH SAN FRANCISCO, Calif., Sept. 05, 2017 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading "off-the-shelf" T-cell immunotherapy company developing novel treatments for patients with cancer and autoimmune diseases, today …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology

Published on September 5, 2017 - 12:00 GMT

FuelCell Energy Announces 20 Megawatt Fuel Cell Project with Korea Southern Power Company

DANBURY, Conn., Sept. 05, 2017 (GLOBE NEWSWIRE) -- FuelCell Energy, Inc. (Nasdaq:FCEL), a global leader in delivering clean, innovative and affordable fuel cell solutions for the supply, recovery and storage of energy, today announced a 20 megawatt fuel …

Distribution channels: Banking, Finance & Investment Industry, Electronics Industry